News & Events

December 4, 2025

Press release | LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes

Read More

Upcoming Events

Jan 13

JPM Healthcare Conference

Jan 19

PepTalk

Jan 19

BioLogic Summit
November 9, 2023

Podcast | LabGenius’ CEO, James Field, discusses ML-enabled drug discovery with Patrick Short on the Genetics Podcast

Listen Here
LabGenius Therapeutics pwc
October 19, 2023

Report | The Life Sciences Future50

Read More
LabGenius Therapeutics on The Bio Report
September 27, 2023

Podcast | Leveraging Generative AI to Design Therapeutic Antibodies

Read More
September 18, 2023

Press release | LabGenius’ Research Collaboration with Sanofi Yields Positive Results

Read More
LabGenius Therapeutics TechCrunch
September 18, 2023

Article | Questions Every VC Needs to Ask About Every AI Startup’s Tech Stack

Read More
LabGenius Therapeutics synbiobeta
September 18, 2023

Article | Machine Learning Enhances Antibody Discovery: A Glimpse into LabGenius and Sanofi’s Collaborative Endeavour

Read More
LabGenius Therapeutics Wired
August 9, 2023

Article | AI is Building Highly Effective Antibodies That Humans Can’t Even Imagine

Read More
LabGenius Therapeutics in Business of Biotech
July 7, 2023

Podcast | LabGenius’ CEO, James Field, discusses ML-enabled drug discovery as a recent guest on the Business of Biotech podcast

Read More
May 15, 2023

Press release | LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark

Read More
Load More